Inventaire - your friends and communities are your best library

Overexpression of C16orf74 is involved in aggressive pancreatic cancers

author

Toyomasa Katagiri

published in: Oncotarget

date of publication: 2016-07-28

language: English

main subject: overexpression

Cites articles 38

Date

Title

Authors

2014-10-24

Postoperative prognosis of pancreatic cancer with para-aortic lymph node metastasis: a multicenter study on 822 patients
2013-10-16

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

Josep Tabernero Caturla, Manuel Hidalgo
2012-10-01

Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

ESMO Guidelines Working Group
2012-05-29

Dynamic change of chromatin conformation in response to hypoxia enhances the expression of GLUT3 (SLC2A3) by cooperative interaction of hypoxia-inducible factor 1 and KDM3A

Teppei Shimamura, Juro Sakai, Hiroyuki Aburatani
2011-11-30

Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patients

Kimitaka Tanaka, Soldano Ferrone, Toshiaki Shichinohe
2011-12-02

Novel combination markers for predicting progression of nonmuscle invasive bladder cancer

Seok-joong Yun, Pildu Jeong, Wun-Jae Kim
2011-05-12

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer
2011-07-23

The effect of down regulation of calcineurin Aα by lentiviral vector-mediated RNAi on the biological behavior of small-cell lung cancer and its bone metastasis
2010-12-21

Identification of C16orf74 as a marker of progression in primary non-muscle invasive bladder cancer

Seok-joong Yun, Wun-Jae Kim
2010-08-19

Primers on molecular pathways--the NFAT transcription pathway in pancreatic cancer

Martín E Fernández-Zapico
2010-07-06

Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205

Eileen M. O'Reilly, Alok A Khorana, Cecilia M. Fenoglio-Preiser
2010-07-06

Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303)

Eileen M. O'Reilly, Federico Innocenti
2010-04-27

Calcineurin promotes proliferation, migration, and invasion of small cell lung cancer
2010-01-08

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer

Seok-joong Yun, Pildu Jeong
2009-11-06

NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells

Thomas Gress, Guido Adler
2009-04-02

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

Geert D'Haens, Sabine Tejpar, Claus-Henning Köhne, Eric Van Cutsem, Gunnar Folprecht, György Bodoky
2009-04-01

Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies

Bradly Wouters, Peter J. Ratcliffe, Adrian Harris, Andrea Scozzafava, Jochen Kieninger, Agnes Görlach, Thomas Gorr, Peter Ebbesen, Kaye J Williams, Ludwig Dubois, Claudiu T Supuran, Silvia Pastoreková
2009-01-23

Low-level expression of Smad7 correlates with lymph node metastasis and poor prognosis in patients with pancreatic cancer
2008-09-01

Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis

Josée Dupuis, Ronenn Roubenoff, Wentian Li, Peter K. Gregersen
2008-04-14

Overexpression of calcineurin B subunit (CnB) enhances the oncogenic potential of HEK293 cells
2007-05-20

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group
2007-01-27

An emerging role for Ca2+/calcineurin/NFAT signaling in cancerogenesis
2007-04-01

Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers

Crispin J. Miller, Nicholas J Slevin, Catharine M. West, Adrian Harris, Philip Sloan
2007-07-01

Correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase III studies
2006-11-01

Global expression-based classification of lymph node metastasis and extracapsular spread of oral tongue squamous cell carcinoma
2006-07-27

Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway

Thomas Gress, Guido Adler
2006-02-27

NFAT induces breast cancer cell invasion by promoting the induction of cyclooxygenase-2.
2005-06

NFAT proteins: key regulators of T-cell development and function

Fernando Macian
2005-01-04

Expression and function of the nuclear factor of activated T cells in colon carcinoma cells: involvement in the regulation of cyclooxygenase-2.
2004-05-01

Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro

Keita Odashiro, Toshihiro Tanaka, Kouichi Ozaki
2004-03-01

Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection

Toyomasa Katagiri, Hidewaki Nakagawa
2003-10-01

Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex

Takashi Shimokawa

Article - wd:Q41612086

Welcome to Inventaire

the library of your friends and communities

learn more